Patents Assigned to Brightpulse Holding Ltd.
  • Protein SLURP-1 for use in the treatment of ocular diseases
    Patent number: 10098925
    Abstract: The present invention relates to a protein comprising SEQ ID NO:1 (mature form of SLURP-1) and to a composition comprising the same for use in inducing or accelerating cicatrization, and/or in preventing infection in the eye of a subject.
    Type: Grant
    Filed: December 9, 2013
    Date of Patent: October 16, 2018
    Assignee: Brightpulse Holding Ltd.
    Inventors: Jean-Marc Combette, Catherine Deloche, Claire Abadie, Sebastien Mouz, Julien Perino